For three weeks, beginning May 4 and ending May 24, the Department of Health and Human Services said it delivered to states, territories and government agencies more than 12,000 cases of 40 vials each of remdesivir to help treat COVID-19 infections.

Every state and territory has received at least one shipment, and hospitals are asked to continue inputting data for future allocations. The administration said 80% of the allocated drugs was based on the number of confirmed or suspected COVID-19 cases reported in the TeleTracking platform. Less than 10% of Gilead Sciences Inc.’s original 600,000 vial donation is being held for emerging hotspots, and Gilead said it plans to donate an additional 330,000 vials by the end of June.

Related News Articles

Headline
As urged by the AHA, the Department of Health and Human Services today renewed the COVID-19 public health emergency declaration for another 90 days…
Headline
The Centers for Medicare & Medicaid Services today released updated interpretive guidance on its Omnibus COVID-19 Health Care Staff Vaccination…
Perspective
Record-high COVID-19 hospitalizations and cases. Unprecedented workforce shortages. Persistent supply chain challenges.  These are only a few of the many…
Blog
To help hospitals and health system leaders stay up-to-date on all of the legal developments related to vaccine mandates, the AHA has developed a blog…
Headline
The U.S. Supreme Court today allowed the Centers for Medicare & Medicaid Services vaccine mandate to go into effect nationwide while blocking the…
Headline
Leaders from the AHA and the American College of Obstetricians and Gynecologists, hospital leaders, clinicians and experts from the Centers for Disease Control…